1. Bedard K, Krause KH. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87 (1): 245-313. [PMID:17237347]
2. Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269 (1-2): 131-40. [PMID:11376945]
3. Durand N, Storz P. (2017) Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev Anticancer Ther, 17 (1): 19-31. [PMID:27841037]
4. Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB et al.. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol, 154 (4): 879-91. [PMID:11514595]
5. Freund-Michel V, Guibert C, Dubois M, Courtois A, Marthan R, Savineau JP, Muller B. (2013) Reactive oxygen species as therapeutic targets in pulmonary hypertension. Ther Adv Respir Dis, 7 (3): 175-200. [PMID:23328248]
6. Ghatak S, Hascall VC, Markwald RR, Feghali-Bostwick C, Artlett CM, Gooz M, Bogatkevich GS, Atanelishvili I, Silver RM, Wood J et al.. (2017) Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem, 292 (25): 10490-10519. [PMID:28389561]
7. Guzik TJ, Harrison DG. (2006) Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today, 11 (11-12): 524-33. [PMID:16713904]
8. Lambeth JD. (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol, 4 (3): 181-9. [PMID:15039755]
9. Lambeth JD, Krause KH, Clark RA. (2008) NOX enzymes as novel targets for drug development. Semin Immunopathol, 30 (3): 339-63. [PMID:18509646]
10. Li Y, Pagano PJ. (2017) Microvascular NADPH oxidase in health and disease. Free Radic Biol Med, 109: 33-47. [PMID:28274817]
11. Little AC, Sulovari A, Danyal K, Heppner DE, Seward DJ, van der Vliet A. (2017) Paradoxical roles of dual oxidases in cancer biology. Free Radic Biol Med, 110: 117-132. [PMID:28578013]
12. Lu J, Risbood P, Kane Jr CT, Hossain MT, Anderson L, Hill K, Monks A, Wu Y, Antony S, Juhasz A et al.. (2017) Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. Biochem Pharmacol, 143: 25-38. [PMID:28709950]
13. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. (2015) Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol, 31 (5): 631-41. [PMID:25936489]
14. van der Vliet A, Danyal K, Heppner DE. (2018) Dual oxidase: a novel therapeutic target in allergic disease. Br J Pharmacol, 175 (9): 1401-1418. [PMID:29405261]